spacer
home > pmps > Winter 2003
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2003
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS
   
Text
PDF
Industry Insight 
In her Editor's Letter, Dr Patricia Lobo reviews the articles in this issue of PMPS  
view
bullet
Packaging, Packing & Anti-Counterfeiting
Are the right patients receiving the right drugs in the right dosage at the right time? Eric Tjoa, CEO at Tjoapack BV, reveals all in The Ultimate Solution for Reducing Medication Errors  
view
Phil Donaldson, Director of Sales and Marketing at the ALS Group, offers an insight into labelling developments, in Labelling Trends Expand Market Opportunities  
view
In Trends in Pharmaceutical Packaging, Bernard C Fenner, Head of Marketing at SIG Pack Systems, looks at future developments in the pharmaceutical sector and the implications for packaging machinery  
view
Following the accidental death of a toddler, Jonathan Bobbett, Managing Director at Pill protectTM, highlights the need for improvements, in The Countdown Starts for Implementing New Child-Resistant/Senior-Friendly Blister Packaging  
view
In Brand Protection: A Stitch in Time!, Kate Hinsley, Head of Marketing Communications at De La Rue Security Print, argues for improved anti-counterfeiting measures  
view
bullet
Formulations, Ingredients and Excipients
Dr Detlef Wilke, Partner at Biotech Consulting GmbH and Jens A Katzek, Managing Director of BIO-Mitteldeutschland GmbH, consider plants as alternative eukaryotic expression systems, in Primary Production of Biopharmaceuticals in Plants - An Economically Attractive Choice?  
view
In Standardised Extracts and Traditional Herbal Remedies Versus Pharmaceutical Drugs, Andrea Zangara, Research Associate, Jessica Goford, Lead Senior Research Associate and Tamsin Manktelow, Scientific Development Manager at Cognitive Drug Research, discuss the reasons why natural products tend to have less evidence to support their efficacy than commercial drugs  
view
In the near future Britain should become the first country to license a cannabis-based pharmaceutical. David Potter at GW Pharmaceuticals, offers his expertise, in Medicinal Cannabis Production - The Botanist's View  
view
Dr Trevor Theobald, Business Development Director, Indira Walker, Quality and Regulatory Affairs Director and Dr Christopher Stewart, Botanical Sourcing Manager at Kings, examine why every company using plant-based ingredients in their products faces a number of sourcing challenges, in Quality and Risk Management in Botanical Supply Chains  
view
bullet
STERILE MANUFACTURING
New Developments in the Containment of Pharmaceutical Powders are identified and discussed by Martyn Ryder, Managing Director of Extract Technology, part of the Carlisle Life Sciences Group  
view
Richard Paley, Principal Architect and Pharmaceutical Consultant at Bovis Lend Lease, gives an insight into the complex process of cleanroom design, in Designing Biopharma and Pharmaceutical Cleanrooms  
view
bullet
Drug Delivery
Advancements in biotechnology and bioprocessing are driving the rapid development, commercialisation and availability of biopharmaceuticals globally, as explained in Reinventing Biopharmaceutical Manufacturing with Single-Use Disposable Systems, by Carolyn Franceschi, Medical Business Unit Manager at Colder Products Company  
view
Jon Tuckwell, Head of Drug Delivery at Cambridge Consultants, considers the options available to patients in Dry Powder Inhalers - The Best Alternative Drug Delivery Method?  
view
In Taking Nasal Drug Delivery Seriously: Examples of Pain-Free and User-Friendly Alternatives, Pierre Carlotti, Marketing Director at Valois Pharmaceutical Division, explores the direct transport of drugs from the nasal cavity to the central nervous system  
view
bullet
MANUFACTURING
In Manufacturing Hazardous Biologicals: Practical Considerations, Dr Howard S Tranter of the Health Protection Agency assesses why particular attention should be made to assessing the hazards and risks posed to process operator safety during their manufacture  
view
The conservative approach taken to evaluate and qualify water systems used for aseptic pharmaceutical manufacturing, as regulated by the FDA, is discussed by Hank Hicks, Validation Director and David Bosch, Validation Manager, at Pharmaceutical Systems, in Aseptic Pharmaceutical Manufacturing: The Design and Validation of Water for Injection Systems  
view
Adrian Howson, Managing Consultant in Health Care Process Development at PA Consulting Group, identifies key concerns and offers practical solutions, in Why the Health Care Industry Needs a New Approach to Automated Testing  
view
Vertical and Horizontal Integration Offers Supplier Partnerships in Drug Development and Manufacturing - Gerrit van den Dool, Vice President, Europe at Sigma-Aldrich Inc, reflects on the pharma supply industry's transition from being a smaller niche player to a key partner providing a single source of supply
 
view
Risks associated with the operation of isolators, microbials and particulate contamination used for aseptic processing activities are highlighted by Tim Sandle, Microbiologist at Bio Products Laboratory (BPL), in General Considerations for the Risk Assessment of Isolators used for Aseptic Processes  
view
In an interview with Maurice Wolridge, CEO of FAMAR, Patricia Lobo, Editor of PMPS and Senior Consultant at Technomark Consulting Services, asks about The Future of Manufacturing - Is Outsourcing the Solution?  
view
bullet
LOGISTICS
Jamie French, Operations Manager at Biocair, identifies the key issues logistics providers must tackle in order to satisfy client's expectations of more efficient and successful trials, in Clinical Trials - Meeting the Logistics Challenge  
view
According to analysts, the pharmaceutical industry will soon be increasing investments in manufacturing automation and information systems. Edwin Mus, Technical Director at Stevo ICT Tools BV investigates, in the True Benefits of Manufacturing Information Systems through Vast Integration  
view
In Validation - Walk the Talk, Bash Hemani, Managing Director at C4Consulting and Stig Werner, Senior Validation Manager for Europe Pharma Companies, pose the question: does your validation processes measure up?  
view
Peter Van Buren, Sales Director at Introtech bv and Co-Director at Blanken Controls bv, discusses Monitoring Pharmaceuticals During Storing, Handling and Transportation by Means of Indicators  
view
Paul Mayer, Sales Director at Braby, invites you to Take the Hassle Out of Buying a Vessel  
view
In Success Factors for the Cargo Transportation of Pharmaceuticals, PMPS talks to Francis Ramuz, Cool Products Specialist at Swiss WorldCargo  
view
bullet
REVIEW
Is Pharmaceutical Manufacturing now a Contracting Business Proposition? Dr Charles E Horth, Life Science Consulting Editor, reports on the 8th Annual 'Vision in Business' Conference on Contract Manufacturing, 2003  
view
   
spacer
Edited by
Randice Altschul
Chief Executive Officer at Pop Test and Palisades Therapeutics

Published quarterly in
February, May,
August, and November

News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Key to Outsourcing Method Development and Validation: A Pragmatic Approach

RSSL

In an industry that is seeing an increasing level of work being outsourced, the Contract Research Organisation (CRO) of choice needs to have proven experience in both the pragmatism and flexibility of the method developerís mind set and a regulatory background in validation. As companies are focussing on achieving ever shorter times of drug to market, it is vital that a tailored, pragmatic approach is adopted when engaging in both method development and validation activities for an Active Pharmaceutical Ingredient (API) or drug product (DP). Although methods still require a high degree of robustness, the overall strategy should encompass a full evaluation of the regulatory requirements applicable to the particular phase of the drug life-cycle; this is pivotal in Key to Outsourcing Method Development and Validation A Pragmatic Approach order to ensure a successful regulatory submission, where the applicant must demonstrate suitable validation of all methods used to support the filing.
More info >>

Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement